Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...

The Cawley Center for Translational Cancer Research, a lab within the Helen F. Graham Cancer Center & Research Institute in Newark, has just launched its organoid core facility. It will focus on tumor ...

Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...

Shepherd says that women who visit the hospital with a suspicious ovarian finding will undergo the standard diagnostic ...

A 46-year-old woman, diagnosed with high-grade serous adenocarcinoma of the ovary, has made a successful recovery after ...

A woman, who organised a series of charity music festivals after being diagnosed with ovarian cancer, is to launch a support group for other women living with the disease. Dot Bailey, from ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease. Ovarian ...

“It’s being very well managed,” the international journalist said of her second ovarian cancer recurrence Max Cisotti/Dave Benett/Getty Christiane Amanpour revealed that her ovarian cancer has ...

Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-approved indications, the drug is showing it still has unfinished business. In the ...

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...